2023
DOI: 10.1021/jacsau.2c00712
|View full text |Cite
|
Sign up to set email alerts
|

The Evolving Nature of Biocatalysis in Pharmaceutical Research and Development

Abstract: Biocatalysis is a highly valued enabling technology for pharmaceutical research and development as it can unlock synthetic routes to complex chiral motifs with unparalleled selectivity and efficiency. This perspective aims to review recent advances in the pharmaceutical implementation of biocatalysis across early and late-stage development with a focus on the implementation of processes for preparative-scale syntheses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
39
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(39 citation statements)
references
References 116 publications
(182 reference statements)
0
39
0
Order By: Relevance
“…142 KREDs and ADHs have been widely used and engineered to synthesize chiral alcohols. 143 One example of site-selective KRED biocatalysis involves reduction of triketone 127 to the corresponding dihydro iso-alpha acid 128 (Scheme 22A). Directed evolution was used to engineer a site-selective KRED for this transformation.…”
Section: Carbonyl Reductionmentioning
confidence: 99%
See 1 more Smart Citation
“…142 KREDs and ADHs have been widely used and engineered to synthesize chiral alcohols. 143 One example of site-selective KRED biocatalysis involves reduction of triketone 127 to the corresponding dihydro iso-alpha acid 128 (Scheme 22A). Directed evolution was used to engineer a site-selective KRED for this transformation.…”
Section: Carbonyl Reductionmentioning
confidence: 99%
“…Representative AKRs include aldose reductases, aldehyde reductases, hydroxysteroid dehydrogenases, ketoreductases (KREDs), and alcohol dehydrogenases (ADHs) . KREDs and ADHs have been widely used and engineered to synthesize chiral alcohols . One example of site-selective KRED biocatalysis involves reduction of triketone 127 to the corresponding dihydro iso-alpha acid 128 (Scheme A).…”
Section: Functional Group Manipulationmentioning
confidence: 99%
“…For example, organic substrates may have limited solubility in water, but this can often be solved by using a cosolvent or by modulating the substrate to be more soluble in water. In some instances, even poorly water-soluble substrates can still deliver high yields on process scales . In addition, if the enzyme is inefficient at catalyzing a desired reaction, the substrate can sometimes be engineered to more closely match the native substrate of the enzyme .…”
Section: Biocatalysis Todaymentioning
confidence: 99%
“…142 KREDs and ADHs have been widely used and engineered to synthesize chiral alcohols. 143 One example of site-selective KRED biocatalysis involves reduction of tri-ketone 127 to the corresponding dihydro iso-alpha acid 128 (Scheme 22A). Directed evolution was used to engineer a site-selective KRED for this transformation.…”
Section: Carbonyl Reductionmentioning
confidence: 99%